Cargando…
Could the female-to-male transgender population be donor candidates for uterus transplantation?
OBJECTIVE: To evaluate the eligibility of female-to-male (FtM) transgender people as donor candidates with regard to histologic, surgical, and social aspects. MATERIALS AND METHODS: In this prospective cohort study, 31 FtM transgender people underwent standard hysterectomy and bilateral salpingo-oop...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780567/ https://www.ncbi.nlm.nih.gov/pubmed/29379666 http://dx.doi.org/10.4274/tjod.55453 |
_version_ | 1783294768302784512 |
---|---|
author | Api, Murat Boza, Ayşen Ceyhan, Mehmet |
author_facet | Api, Murat Boza, Ayşen Ceyhan, Mehmet |
author_sort | Api, Murat |
collection | PubMed |
description | OBJECTIVE: To evaluate the eligibility of female-to-male (FtM) transgender people as donor candidates with regard to histologic, surgical, and social aspects. MATERIALS AND METHODS: In this prospective cohort study, 31 FtM transgender people underwent standard hysterectomy and bilateral salpingo-oophorectomy for gender reassignment upon their request. The pelvic viscera of the transgender people was intraoperatively observed and the histology of the removed uteri were evaluated for fertility capacity and procurement surgery. A questionnaire was administered to explore their attitude towards uterus donation. RESULTS: The mean ± standard deviation age was 28.5±5 years. The median duration of testosterone supplementation was 2.4 years; therefore, they all had irregular menstrual periods during this therapy. None had any previous abdominal surgery or additional morbidity. The mean uterine volume was 138±48 cm(3). No adenomyosis, endometriosis, polyps, adhesions or uterine anomalies were either observed or reported. Endometrial histology was reported as proliferative (58%), atrophic (29%), and secretory (13%) pattern. Of the 31 transgender people, 30 (96.7%) had a positive attitude; only one had no opinion at the beginning. After detailed information about the procedure was given, 26 (84%) still wanted to volunteer for donation, but 4 (12%) changed their opinion to negative (p=0.12, McNemar test). CONCLUSION: The proposal of the FtM transgender population as uterus donor is a hypothetical model that has not been experienced before. Nevertheless, our experience revealed that the FtM transgender population would be good candidates socially, legally, and biologically. |
format | Online Article Text |
id | pubmed-5780567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-57805672018-01-29 Could the female-to-male transgender population be donor candidates for uterus transplantation? Api, Murat Boza, Ayşen Ceyhan, Mehmet Turk J Obstet Gynecol Clinical Investigation OBJECTIVE: To evaluate the eligibility of female-to-male (FtM) transgender people as donor candidates with regard to histologic, surgical, and social aspects. MATERIALS AND METHODS: In this prospective cohort study, 31 FtM transgender people underwent standard hysterectomy and bilateral salpingo-oophorectomy for gender reassignment upon their request. The pelvic viscera of the transgender people was intraoperatively observed and the histology of the removed uteri were evaluated for fertility capacity and procurement surgery. A questionnaire was administered to explore their attitude towards uterus donation. RESULTS: The mean ± standard deviation age was 28.5±5 years. The median duration of testosterone supplementation was 2.4 years; therefore, they all had irregular menstrual periods during this therapy. None had any previous abdominal surgery or additional morbidity. The mean uterine volume was 138±48 cm(3). No adenomyosis, endometriosis, polyps, adhesions or uterine anomalies were either observed or reported. Endometrial histology was reported as proliferative (58%), atrophic (29%), and secretory (13%) pattern. Of the 31 transgender people, 30 (96.7%) had a positive attitude; only one had no opinion at the beginning. After detailed information about the procedure was given, 26 (84%) still wanted to volunteer for donation, but 4 (12%) changed their opinion to negative (p=0.12, McNemar test). CONCLUSION: The proposal of the FtM transgender population as uterus donor is a hypothetical model that has not been experienced before. Nevertheless, our experience revealed that the FtM transgender population would be good candidates socially, legally, and biologically. Galenos Publishing 2017-12 2017-12-30 /pmc/articles/PMC5780567/ /pubmed/29379666 http://dx.doi.org/10.4274/tjod.55453 Text en ©Copyright 2017 by Turkish Society of Obstetrics and Gynecology Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigation Api, Murat Boza, Ayşen Ceyhan, Mehmet Could the female-to-male transgender population be donor candidates for uterus transplantation? |
title | Could the female-to-male transgender population be donor candidates for uterus transplantation? |
title_full | Could the female-to-male transgender population be donor candidates for uterus transplantation? |
title_fullStr | Could the female-to-male transgender population be donor candidates for uterus transplantation? |
title_full_unstemmed | Could the female-to-male transgender population be donor candidates for uterus transplantation? |
title_short | Could the female-to-male transgender population be donor candidates for uterus transplantation? |
title_sort | could the female-to-male transgender population be donor candidates for uterus transplantation? |
topic | Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780567/ https://www.ncbi.nlm.nih.gov/pubmed/29379666 http://dx.doi.org/10.4274/tjod.55453 |
work_keys_str_mv | AT apimurat couldthefemaletomaletransgenderpopulationbedonorcandidatesforuterustransplantation AT bozaaysen couldthefemaletomaletransgenderpopulationbedonorcandidatesforuterustransplantation AT ceyhanmehmet couldthefemaletomaletransgenderpopulationbedonorcandidatesforuterustransplantation |